Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors - A Systematic Review

CONCLUSION: FCR is common in thyroid cancer survivors but significant heterogeneity in the current evidence base limits assessment of incidence, severity or risk factors. There is a need to use validated tools to assess FCR in both research and clinical contexts. Reliable assessment of FCR may permit routine assessment of FCR in clinical practice and allow interventions to be prospectively evaluated to optimise the holistic well-being of thyroid cancer survivors.PMID:38368547 | DOI:10.1089/thy.2023.0642
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Authors: Source Type: research